Abbvie (ABBV) Holder Jlb & Associates Has Trimmed Holding by $475,264 as Market Valuation Declined; Omega Healthcare Invs (OHI) Share Price Rose While Cutter & Company Brokerage Cut Its Holding

Omega Healthcare Investors, Inc. (NYSE:OHI) Logo

Jlb & Associates Inc decreased its stake in Abbvie (ABBV) by 7.47% based on its latest 2018Q3 regulatory filing with the SEC. Jlb & Associates Inc sold 5,056 shares as the company’s stock declined 6.62% with the market. The institutional investor held 62,606 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $5.92 million, down from 67,662 at the end of the previous reported quarter. Jlb & Associates Inc who had been investing in Abbvie for a number of months, seems to be less bullish one the $132.67 billion market cap company. The stock increased 0.44% or $0.39 during the last trading session, reaching $88.2. About 6.53 million shares traded. AbbVie Inc. (NYSE:ABBV) has declined 7.04% since January 11, 2018 and is downtrending. It has underperformed by 7.04% the S&P500. Some Historical ABBV News: 11/04/2018 – Fujifilm Kyowa Kirin Biologics Partners with Mylan to Commercialize Biosimilar to Humira® (adalimumab); 24/05/2018 – ABBVIE – STUDY MET PRIMARY ENDPOINT FOR CLINICALLY, STATISTICALLY SIGNIFICANT DIFFERENCE IN PFS FOR PATIENTS TREATED WITH IMBRUVICA PLUS OBINUTUZUMAB; 09/04/2018 – AbbVie’s promised rheumatoid arthritis blockbuster upadacitinib hits its marks in another PhIII – this time without any deaths $ABBV; 23/05/2018 – MERCK & CO – SUBMITTED SBLA FOR KEYTRUDA IN COMBINATION TO U.S. FDA AND NEW DATA WILL BE SHARED WITH AGENCY; 09/04/2018 – KEYTRUDA® (PEMBROLIZUMAB) MONOTHERAPY MET PRIMARY ENDPOINT IN; 26/04/2018 – AbbVie’s Blockbuster Humira Resilient as Drugmaker Seeks New Hit; 23/05/2018 – MERCK & CO INC – KEYTRUDA COMBINATION MET DUAL PRIMARY ENDPOINTS OF OVERALL SURVIVAL (OS) AND PROGRESSION-FREE SURVIVAL (PFS) IN STUDY; 23/05/2018 – MERCK & CO’S KEYTRUDA® (PEMBROLIZUMAB) SIGNIFICANTLY IMPROVED; 21/03/2018 – AbbVie and the Intl Myeloma Foundation Announce Partnership to Study the Role of a Genetic Mutation in Outcomes of Patients With Multiple Myeloma; 30/05/2018 – GILEAD SCIENCES INC – EPCLUSA IS FIRST PAN-GENOTYPIC HCV SINGLE TABLET REGIMEN (STR) APPROVED IN CHINA

Cutter & Company Brokerage Inc decreased its stake in Omega Healthcare Invs (OHI) by 79.29% based on its latest 2018Q3 regulatory filing with the SEC. Cutter & Company Brokerage Inc sold 29,177 shares as the company’s stock rose 12.63% while stock markets declined. The institutional investor held 7,623 shares of the consumer services company at the end of 2018Q3, valued at $250,000, down from 36,800 at the end of the previous reported quarter. Cutter & Company Brokerage Inc who had been investing in Omega Healthcare Invs for a number of months, seems to be less bullish one the $7.78 billion market cap company. The stock increased 1.01% or $0.37 during the last trading session, reaching $36.84. About 2.20M shares traded. Omega Healthcare Investors, Inc. (NYSE:OHI) has risen 37.38% since January 11, 2018 and is uptrending. It has outperformed by 37.38% the S&P500. Some Historical OHI News: 21/04/2018 – DJ Omega Healthcare Investors Inc, Inst Holders, 1Q 2018 (OHI); 14/05/2018 – OMEGA HEALTHCARE INVESTORS INC – RECEIVED COURT APPROVAL TO BEGIN ORDERLY TRANSITION TO NEW OPERATORS OF 23 OF 42 FACILITIES; 07/05/2018 – Omega Healthcare 1Q Rev $220.2M; 09/05/2018 – TABLE-Japan nuclear reactor operations: Kansai restarts Ohi No.4; 07/03/2018 – OMEGA HEALTHCARE INVESTORS – CO HAS PROVIDED A COMMITMENT FOR UP TO $30 MLN IN DEBTOR-IN-POSSESSION (“DIP”) FINANCING TO PROVIDE LIQUIDITY TO THE DEBTORS; 07/05/2018 – OMEGA HEALTHCARE INVESTORS INC OHI.N – AFFIRMED ITS 2018 ADJUSTED FFO GUIDANCE OF $2.96 TO $3.06 PER DILUTED SHARE; 13/04/2018 – Omega Announces Second Quarter Dividend and Annual Meeting Dates; 14/05/2018 – OMEGA HEALTHCARE INVESTORS – ON MAY 11, BANKRUPTCY COURT APPROVED ON FINAL BASIS $30 MLN SENIOR SECURED DIP FINANCING PROVIDED BY OMEGA TO ORIANNA; 07/05/2018 – Omega Healthcare 1Q FFO 71c/Sh; 04/04/2018 – CEO Pickett Gifts 600 Of Omega Healthcare Investors Inc

Since August 17, 2018, it had 0 buys, and 6 insider sales for $26.66 million activity. Another trade for 16,850 shares valued at $1.50M was made by GONZALEZ RICHARD A on Tuesday, December 11. On Friday, August 17 the insider SEVERINO MICHAEL sold $4.88 million. 42,450 shares valued at $3.82M were sold by Gosebruch Henry O on Thursday, November 29. $8.81M worth of stock was sold by Schumacher Laura J on Tuesday, December 4.

Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on January, 25 before the open. They expect $1.92 EPS, up 29.73% or $0.44 from last year’s $1.48 per share. ABBV’s profit will be $2.89 billion for 11.48 P/E if the $1.92 EPS becomes a reality. After $2.14 actual EPS reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts -10.28% negative EPS growth.

Investors sentiment decreased to 0.82 in Q3 2018. Its down 0.12, from 0.94 in 2018Q2. It worsened, as 60 investors sold ABBV shares while 637 reduced holdings. 107 funds opened positions while 466 raised stakes. 994.12 million shares or 0.91% less from 1.00 billion shares in 2018Q2 were reported. Capital City Tru Com Fl reported 1.14% stake. Rothschild Inv Corporation Il holds 179,295 shares or 2% of its portfolio. 1.28 million are owned by Keybank Association Oh. Alley Llc owns 87,010 shares. State Teachers Retirement System has 0.56% invested in AbbVie Inc. (NYSE:ABBV). Overbrook Management Corporation stated it has 0.65% of its portfolio in AbbVie Inc. (NYSE:ABBV). Beaumont Prtn Ltd Co stated it has 6,269 shares. Pennsylvania Tru owns 0.79% invested in AbbVie Inc. (NYSE:ABBV) for 201,913 shares. Deprince Race & Zollo Incorporated reported 260,414 shares. Wellington Shields And Com Lc owns 19,322 shares for 0.99% of their portfolio. Eagle Ridge Invest Mgmt holds 1.4% in AbbVie Inc. (NYSE:ABBV) or 102,637 shares. Fort Washington Advisors Oh has 103,957 shares for 0.1% of their portfolio. Pekin Singer Strauss Asset Management Il holds 36,196 shares or 0.63% of its portfolio. Thompson Investment holds 1.08% or 63,967 shares in its portfolio. Whittier accumulated 212,232 shares.

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Seekingalpha.com which released: “FDA to “take action” against branded drug makers using scare tactics to thwart biosimilar competition – Seeking Alpha” on January 10, 2019, also Seekingalpha.com with their article: “AbbVie boosts stock buybacks by $5B – Seeking Alpha” published on December 13, 2018, Seekingalpha.com published: “Pfizer withdraws European marketing application for Humira biosimilar – Seeking Alpha” on December 14, 2018. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Seekingalpha.com and their article: “J&J weighing on big biopharma players – Seeking Alpha” published on December 14, 2018 as well as Seekingalpha.com‘s news article titled: “AbbVie revamps senior management – Seeking Alpha” with publication date: December 17, 2018.

Among 26 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 3 Sell and 13 Hold. Therefore 38% are positive. Abbvie Inc had 105 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Hold” rating by Piper Jaffray given on Friday, June 1. The stock has “Equal-Weight” rating by Barclays Capital on Tuesday, December 1. Credit Suisse maintained the stock with “Neutral” rating in Friday, April 27 report. The firm has “Hold” rating given on Friday, July 28 by Cowen & Co. Morgan Stanley downgraded it to “Equal-Weight” rating and $65 target in Wednesday, June 8 report. SunTrust maintained AbbVie Inc. (NYSE:ABBV) rating on Sunday, October 29. SunTrust has “Buy” rating and $105.0 target. The stock of AbbVie Inc. (NYSE:ABBV) earned “Market Perform” rating by BMO Capital Markets on Thursday, November 16. The stock of AbbVie Inc. (NYSE:ABBV) earned “Hold” rating by Deutsche Bank on Thursday, September 28. The stock of AbbVie Inc. (NYSE:ABBV) has “Underperform” rating given on Wednesday, May 23 by BMO Capital Markets. The firm has “Outperform” rating by Leerink Swann given on Monday, October 30.

Investors sentiment increased to 1.09 in 2018 Q3. Its up 0.04, from 1.05 in 2018Q2. It is positive, as 32 investors sold OHI shares while 106 reduced holdings. 52 funds opened positions while 98 raised stakes. 141.20 million shares or 0.93% more from 139.89 million shares in 2018Q2 were reported. Pinnacle Partners stated it has 0.02% in Omega Healthcare Investors, Inc. (NYSE:OHI). Virginia Retirement System Et Al reported 202,551 shares stake. Renaissance Tech Limited Liability Corp reported 576,400 shares. State Of Alaska Department Of Revenue has 0.05% invested in Omega Healthcare Investors, Inc. (NYSE:OHI) for 83,824 shares. The Kansas-based Mariner Limited Com has invested 0.02% in Omega Healthcare Investors, Inc. (NYSE:OHI). California State Teachers Retirement Sys holds 318,056 shares or 0.02% of its portfolio. Switzerland-based Zurcher Kantonalbank (Zurich Cantonalbank) has invested 0.01% in Omega Healthcare Investors, Inc. (NYSE:OHI). Proshare Limited Liability Company reported 62,889 shares. 2.14 million are owned by Geode Cap Management Ltd Llc. Cordasco Financial Net invested in 0.04% or 1,150 shares. Wealthtrust Fairport Limited Liability Corp invested in 200 shares. Lodestar Inv Counsel Lc Il owns 38,969 shares for 0.14% of their portfolio. First Hawaiian Bancshares has invested 0.01% in Omega Healthcare Investors, Inc. (NYSE:OHI). Mackenzie Corp stated it has 278,300 shares. Raymond James Svcs Advsr invested in 148,587 shares.

Cutter & Company Brokerage Inc, which manages about $412.24M and $293.19 million US Long portfolio, upped its stake in Visa Inc Class A (NYSE:V) by 3,346 shares to 6,677 shares, valued at $1.00 million in 2018Q3, according to the filing. It also increased its holding in Intl Flavor Fragrance (NYSE:IFF) by 3,280 shares in the quarter, for a total of 19,828 shares, and has risen its stake in Apache Corp Common (NYSE:APA).

Analysts await Omega Healthcare Investors, Inc. (NYSE:OHI) to report earnings on February, 12. They expect $0.74 earnings per share, down 6.33% or $0.05 from last year’s $0.79 per share. OHI’s profit will be $156.18M for 12.45 P/E if the $0.74 EPS becomes a reality. After $0.77 actual earnings per share reported by Omega Healthcare Investors, Inc. for the previous quarter, Wall Street now forecasts -3.90% negative EPS growth.

Among 12 analysts covering Omega Healthcare Investors (NYSE:OHI), 4 have Buy rating, 1 Sell and 7 Hold. Therefore 33% are positive. Omega Healthcare Investors had 37 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Omega Healthcare Investors, Inc. (NYSE:OHI) earned “Hold” rating by Jefferies on Monday, June 12. The rating was upgraded by Bank of America on Friday, November 16 to “Neutral”. As per Tuesday, February 13, the company rating was maintained by Jefferies. The firm earned “Buy” rating on Wednesday, December 20 by Cantor Fitzgerald. On Monday, May 15 the stock rating was maintained by Jefferies with “Hold”. As per Wednesday, May 16, the company rating was upgraded by Jefferies. The stock of Omega Healthcare Investors, Inc. (NYSE:OHI) earned “Hold” rating by Stifel Nicolaus on Tuesday, August 7. Raymond James upgraded the stock to “Outperform” rating in Friday, November 16 report. On Thursday, February 15 the stock rating was upgraded by Wells Fargo to “Outperform”. Cantor Fitzgerald maintained it with “Buy” rating and $34.0 target in Tuesday, February 13 report.

Since November 16, 2018, it had 0 buys, and 5 insider sales for $1.39 million activity. Another trade for 25,000 shares valued at $931,200 was made by INSOFT STEVEN J on Tuesday, December 11.

Omega Healthcare Investors, Inc. (NYSE:OHI) Institutional Positions Chart